Granules buying FDA-approved plants to speed U.S. push; Perrigo recalling infant suspension liquid;
Granules India is to accelerate its expansion into the U.S. by acquiring Auctus Pharma and its FDA-approved plants. Article
Perrigo ($PRGO) is recalling 18 batches of its acetaminophen infant suspension liquid because some oral syringes may lack dose markings. Release
The Bangladeshi government has vowed to continue its crackdown on fake drugs, despite a backlash against its actions. Feature
Lehigh Valley Technologies is creating 52 jobs as it expands drug production in Pennsylvania. Piece
Repligen has completed a 9,000-square-foot expansion of its manufacturing facilities in Massachusetts. News (PDF)
A survey of mid-sized drugmakers found many think it will take up to 5 years to fully implement a serialization program. Article
Sanofi ($SNY) is planning to upgrade the vaccine plant it runs as a joint venture with the Thai government. Piece
Summary
> Granules India is to accelerate its expansion into the U.S. by acquiring Auctus Pharma and its FDA-approved plants. Article > Perrigo ($PRGO) is recalling 18 batches of its acetaminophen...